Pictures You might have never seen

Menorrhagia is the most common type of abnormal uterine bleeding, and may sometimes become so severe as to interrupt daily activities. In addition, it may be associated with abnormally painful periods, a condition known as dysmenorrhea. According to Kathleen Uhl, M.D., the FDA’s associate commissioner of women’s health, “Menorrhagia can be incapacitating for some women.” She also added, “Heavy menstrual periods can cause pain, mood swings, and disruptions to work and family life.”

The newly FDA approved tranexamic acid, also known as Lysteda, is made is by Newport, Kentucky-based Xanodyne Pharmaceuticals. Lysteda tablets reduce the menstrual flow by working to stabilize a protein that helps blood clot. The FDA first approved the drug in 1986 under the brand name Cyklokapron as an injection for use in the reduction or prevention of bleeding during and following tooth extraction in patients with hemophilia. Hemophilia is a genetic disorder that prevents blood from clotting.